-
Ultimovacs ASA – New share capital registered
-
Ultimovacs ASA – Private placement of new shares successfully placed
-
Ultimovacs ASA – Contemplated private placement
-
Ultimovacs ASA Announces Collaboration with Big Pharma Company and Leading European Oncology Clinical Trial Group to Evaluate UV1 in a Third Phase II Clinical Trial
-
Ultimovacs ASA – Share Option Program
-
Ultimovacs ASA: First quarter 2020 result presentation
-
Ultimovacs ASA: Invitation to first quarter 2020 result webcast presentation
-
Ultimovacs ASA – Annual General Meeting held on 23 April 2020
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs ASA – Notice of Annual General Meeting on 23 April 2020
